Your browser doesn't support javascript.
loading
Transplant center volume and outcomes in lung transplantation for cystic fibrosis.
Hayes, Don; Sweet, Stuart C; Benden, Christian; Kopp, Benjamin T; Goldfarb, Samuel B; Visner, Gary A; Mallory, George B; Tobias, Joseph D; Tumin, Dmitry.
Afiliação
  • Hayes D; Department of Pediatrics, The Ohio State University, Columbus, OH, USA.
  • Sweet SC; Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Benden C; Department of Surgery, The Ohio State University, Columbus, OH, USA.
  • Kopp BT; Center for Epidemiology of Organ Failure and Transplantation, Nationwide Children's Hospital, Columbus, OH, USA.
  • Goldfarb SB; Section of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
  • Visner GA; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
  • Mallory GB; Department of Pediatrics, Pereleman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Tobias JD; Department of Pediatrics, The Ohio State University, Columbus, OH, USA.
  • Tumin D; Center for Epidemiology of Organ Failure and Transplantation, Nationwide Children's Hospital, Columbus, OH, USA.
Transpl Int ; 30(4): 371-377, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28012223
ABSTRACT
Transplant volume represents lung transplant (LTx) expertise and predicts outcomes, so we sought to determine outcomes related to center volumes in cystic fibrosis (CF). United Network for Organ Sharing data were queried for patients with CF in the United States (US) receiving bilateral LTx from 2005 to 2015. Multivariable Cox regression was used to model survival to 1 year and long-term (>1 year) survival, conditional on surviving at least 1 year. A total of 2025 patients and 67 centers were included in the analysis. The median annual LTx volumes were three in CF [interquartile range (IQR) 2, 6] and 17 in non-CF (IQR 8, 33). Multivariable Cox regression in cases with complete data and surviving at least 1 year (n = 1510) demonstrated that greater annual CF LTx volume (HR per 10 LTx = 0.66; 95% CI 0.49, 0.89; P = 0.006) but not greater non-CF LTx volume (HR = 1.00; 95% CI 0.96, 1.05; P = 0.844) was associated with improved long-term survival in LTx recipients with CF. A Wald interaction test confirmed that CF LTx volume was more strongly associated with long-term outcomes than non-CF LTx volume (P = 0.012). In a US cohort, center volume was not associated with 1-year survival. CF-specific expertise predicted improved long-term outcomes of LTx for CF, whereas general LTx expertise was unassociated with CF patients' survival.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Pulmão / Fibrose Cística / Hospitais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Transpl Int Assunto da revista: TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Pulmão / Fibrose Cística / Hospitais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Transpl Int Assunto da revista: TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos